Infectious Disease Diagnostics Market
Infectious Disease Diagnostics Market - Global Industry Assessment & Forecast
#
Pages:
132
2022
Mar - 2022
VMR-1376
Segments Covered
By
Product Reagents, Kits, and Consumables, Instruments, Software & Services
-
By
Type of Testing Laboratory Testing, POC Testing
-
By
Technology Immunodiagnostics, Clinical Microbiology , PCR , INAAT , DNA Sequencing & NGS , DNA Microarrays , Other technologies
-
By
Disease Type COVID-19, HIV , HAIs , Hepatitis , CT/NG , HPV , TB , Influenza , Other Infectious Diseases
-
By
End User Diagnostic Laboratories, Hospitals & Clinics , Academic Research Institutes , Other End Users
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 29632.56 Million |
 Revenue 2030:
|
USD 49041.76 Million |
 Revenue CAGR
(2023 - 2030): |
6.50% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2017 to 2021 |
| 3. | Forecast Data | 2023 to 2030 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
Vantage Market
Research | 16-Mar-2022
FAQ
Frequently Asked Question
What is the global demand for Infectious Disease Diagnostics in terms of revenue?
-
The global Infectious Disease Diagnostics valued at USD 29632.56 Million in 2022 and is expected to reach USD 49041.76 Million in 2030 growing at a CAGR of 6.50%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.50% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Infectious Disease Diagnostics include
- increasing prevalence of infectious diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Infectious Disease Diagnostics in 2022.
